Abiopharma

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

Register of shareholders, changes and share capital status – expiration of warrants after the end of tenure

Datroway recommended for approval in EU for TNBC

General Announcement: Proposed Exercise of Resale Option and Adjustment of Interest Rate for 2023 Second Tranche MTNs

Form 8.3

General Announcement: NOTIFICATION OF RETIREMENT OF NON-EXECUTIVE INDEPENDENT DIRECTORS AT FORTHCOMING AGM IN JANUARY 2027

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

MoU Marks Major Milestone Toward Enabling Ukrainians to Invest in Nasdaq-Listed Kyivstar

Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update